Nath Bio-Genes (India) Limited is a significant entity within India's agricultural sector, specializing in the research, development, production, and marketing of genetically pure and high-quality hybrid seeds. The company is steered by a seasoned leadership team, including Chairman Mr. Nandkishor Kagliwal and Managing Director Mr. Satish Kagliwal. Their core mission is to create value for farmers by developing products tailored to diverse agri-climatic conditions across the country. The company's product portfolio is strategically focused on key crops such as Cotton, Paddy, Maize, Wheat, and Fodder Bajra, with an expanding presence in the vegetable seeds market.

Nath Bio-Genes operates an extensive and deeply entrenched distribution network, comprising approximately 20,000 distributors and dealers, supported by 17 branch offices, 10 processing plants, and a series of warehouses spread across 23 states. This robust infrastructure ensures wide market penetration and an efficient supply chain. The company’s strategy is heavily anchored in its research and development capabilities, with DSIR-recognized innovation centers and a team of experienced scientists. This R&D focus allows them to develop seeds with superior traits, such as high disease and pest resistance, which directly translate to higher yields and better outcomes for the farming community.

Official Website: http://www.nathbiogenes.com/

• Q3 & 9M FY26 Performance: The company demonstrated significant top-line growth. For Q3FY26, Total Revenue increased by 79% YoY to ₹660 Mn. For the nine-month period (9MFY26), Total Revenue grew by 23% YoY to ₹3,859 Mn. This growth was accompanied by a 26% increase in Gross Profit for 9MFY26, reaching ₹2,075 Mn.

• Profitability: For Q3FY26, EBITDA stood at ₹88 Mn, an 18% YoY increase, while Profit After Tax (PAT), excluding extraordinary items, grew 67% YoY to ₹45 Mn. For 9MFY26, EBITDA was largely flat at ₹499 Mn, and PAT saw a marginal 1% increase to ₹399 Mn.

• Segmental Revenue Contribution (9MFY26): The company is successfully diversifying its revenue streams. The contribution from Paddy increased from 19% in 9MFY25 to 26% in 9MFY26. Conversely, the share of Cotton decreased from 28% to 25% over the same period, while 'Others' (including Jowar, Bajra, Maize, Mustard, Wheat) remained the largest contributor at 48% (vs. 46% in the prior year).

• Historical Performance (FY19-FY25): The company has a track record of steady growth, with revenue expanding at an 11% CAGR from ₹1,917 Mn in FY19 to ₹3,623 Mn in FY25.

• Balance Sheet Strength: The company’s financial position has strengthened over time. Net Worth grew consistently from ₹5,943 Mn in FY21 to ₹6,297 Mn in FY25. Notably, Net Debt has seen a significant reduction from a high of ₹888 Mn in FY22 to ₹235 Mn in FY25, indicating improved cash flow management and deleveraging.

The company is exhibiting strong top-line growth and a strategic shift in its revenue mix, supported by a progressively stronger and less leveraged balance sheet.

• Extensive Distribution Network: The company's reach through approximately 20,000 distributors and dealers, 17 branch offices, and a presence in 23 states provides a significant competitive advantage in market penetration and customer access.

• Integrated R&D and Product Development: Nath Bio-Genes operates on a science-led model. It possesses a large and diverse collection of germplasm and employs a team of experienced scientists. Its product development is tailored to farmer requirements, focusing on disease and pest resistance to maximize yield.

• Robust Supply Chain and Infrastructure: The company has well-invested infrastructure, including 10 processing plants and a network of cold storage facilities and warehouses with a capacity of 25,000 MT. This integrated supply chain ensures the production of genetically pure and premium quality seeds.

• Strong Stakeholder Relationships: A core part of the company's strategy is to build long-term, symbiotic relationships with its production growers and organizers, ensuring a reliable and high-quality supply base.

Nath Bio-Genes' competitive edge is built on a combination of its vast distribution network, a deep commitment to tailored R&D, and an integrated supply chain infrastructure.

• Crop-Specific Growth Drivers (9MFY26): The company is witnessing exceptional growth in non-cotton segments.

• Maize: Achieved a 94.77% YoY increase in quantity sold, leading to a 141.98% surge in value.

• Vegetable Seeds: Delivered robust 43.44% YoY growth in quantity, with value increasing by 52.08%.

• Cotton (Bt): The primary revenue driver continues to show steady performance with a 21.35% YoY rise in quantity and 25.26% growth in value.

• Paddy: Recorded healthy 7.75% YoY growth in quantity and an 18.60% increase in value.

• Increasing Average Selling Price (ASP): Between FY18 and FY25, the company achieved a substantial increase in the ASP for both its Field Crops and Vegetable seeds. This indicates strong brand equity, pricing power, and a favorable shift in product mix towards higher-value products.

• Historical Revenue Trajectory: The company's revenue grew from ₹1,917 Mn in FY19 to ₹3,623 Mn in FY25, representing a Compound Annual Growth Rate (CAGR) of 11%.

Growth is being propelled by strong performance in high-potential segments like Maize and Vegetable Seeds, supplementing the steady contribution from the core Cotton business and supported by increasing pricing power.

• Diversification into High-Growth Segments: The exceptional growth in Maize and Vegetable seeds highlights a significant opportunity to diversify revenue streams away from cotton and into these high-margin, high-demand product categories.

• International Expansion: The successful operation of the joint venture in Uzbekistan serves as a strong proof of concept for international expansion. This provides a platform to tap into new geographical markets and further de-risk the business from domestic concentration.

• Product Innovation: The company's focus on developing new and innovative products, such as "Sanket," presents an opportunity to capture new market segments and create additional value for farmers.

Key opportunities for the company lie in diversifying its product portfolio towards high-growth crops and leveraging its successful international joint venture to expand its global footprint.

• Strategic Focus on Diversification: A primary objective is to drive diversification beyond cotton, reducing dependency on a single crop and capturing growth in other areas.

• Accelerate Growth in High-Margin Products: The company plans to strategically focus its efforts on accelerating the growth of products that offer higher profitability, thereby improving overall margin profiles.

• Enhance Operational Efficiency: A stated goal is to enhance operational efficiency across the business to support margin expansion and improve bottom-line performance.

• Strengthen Innovation through R&D: The company will continue to strengthen its innovation pipeline through focused R&D investments to maintain its competitive edge and develop superior products.

The company’s forward-looking strategy is centered on a pivot towards higher-margin products through diversification, coupled with a commitment to operational efficiency and continued R&D-led innovation.

• Recent Margin Performance: In Q3FY26, the Gross Margin stood at 56% and the EBITDA Margin was 13%. For the nine-month period (9MFY26), the EBITDA margin was 14%, compared to 16% in the prior year, indicating some near-term margin pressure.

• Historical EBITDA Margin Trend: Over the long term (FY15-FY25), the company's EBITDA margin has fluctuated, peaking at 22% in FY21 and standing at 14% in FY25. The company has consistently maintained double-digit EBITDA margins.

• Historical PAT Margin Trend: The PAT margin has also shown variability, peaking at 18% in FY21 and recording 11% in FY25.

• Long-Term Gross Margin Improvement: Despite recent quarterly performance, the company's Gross Margin has shown a positive trend over a multi-year period, improving from 56% in FY21 to 63% in FY25.

While facing some margin compression in the recent period, the company has historically maintained healthy profitability levels, with a notable long-term improvement in its gross margin profile.

• General Market and Operating Risks: The company operates in a sector subject to various risks and uncertainties. These include potential impacts from government actions, shifts in local political or economic developments, and technological risks that could affect operations and financial results.

The company acknowledges exposure to standard industry risks, including regulatory, economic, and technological factors that could materially impact its business.

• Successful International Collaboration: The company's joint venture in Uzbekistan is reported to be operating successfully. This achievement strengthens its ongoing business momentum and marks a significant milestone in establishing an international presence.

• Focus on Stakeholder Relationships: The company actively works to empower its stakeholders by building long-term, loyal, and symbiotic relationships with its network of production growers and organizers, which is crucial for maintaining a high-quality supply chain.

A key development is the successful operation of the Uzbekistan joint venture, which validates the company's international expansion strategy and opens avenues for future growth.